IBB ETF holdings (NASDAQ) - Page 3 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

PTGX Protagonist Therapeutics, Inc. 53.0 M 432.4 K 0.6%

RYTM Rhythm Pharmaceuticals, Inc. 52.2 M 470.3 K 0.6%

RGEN Repligen Corp. 51.6 M 378.2 K 0.6%

SYRE Spyre Therapeutics, Inc. 48.6 M 547.7 K 0.5%

BRKR Bruker Corp. 47.4 M 787.5 K 0.5%

PTCT PTC Therapeutics, Inc. 46.3 M 567.9 K 0.5%

N

NUVL Nuvalent, Inc. 45.7 M 370.0 K 0.5%

TWST Twist Bioscience Corp. 43.4 M 422.3 K 0.5%

TEM Tempus AI, Inc. 43.4 M 748.6 K 0.5%

MIRM Mirum Pharmaceuticals, Inc. 41.1 M 351.4 K 0.5%

COGT Cogent Biosciences, Inc. 40.3 M 1.0 M 0.4%

XENE Xenon Pharmaceuticals, Inc. 38.8 M 642.9 K 0.4%

SRRK Scholar Rock Holding Corp. 37.6 M 683.5 K 0.4%

TVTX Travere Therapeutics, Inc. 36.4 M 640.4 K 0.4%

DFTX Definium Therapeutics, Inc. 35.0 M 743.4 K 0.4%

CRSP CRISPR Therapeutics AG 34.6 M 634.6 K 0.4%

ORKA Oruka Therapeutics, Inc. 34.2 M 359.2 K 0.4%

VCYT Veracyte, Inc. 32.4 M 551.4 K 0.4%

TXG 10X Genomics, Inc. 30.6 M 799.3 K 0.3%

LEGN Legend Biotech Corp. 30.4 M 1.1 M 0.3%

1
2
3
4
5
6
7
8
...
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026